United Kingdom Next Generation Sequencing Market By Product (Consumables, Platforms, Services), By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Single Molecule Real Time Sequencing, Others), By Application (Biomarkers & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Agriculture & Animal Research, Others), By End User (Academic & Clini

Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format

View Details Buy Now 2890 Download Sample Ask for Discount Request Customization

United Kingdom Next Generation Sequencing Market By Product (Consumables, Platforms, Services), By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Single Molecule Real Time Sequencing, Others), By Application (Biomarkers & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Agriculture & Animal Research, Others), By End User (Academic & Clini

United Kingdom next generation sequencing market is expected to register robust growth in the forecast period, 2023-2027.

Rise in Genome Mapping Programs is Projected to Catalyze the Market Growth

The decreasing cost of sequencing has allowed governments bodies across United Kingdom to involve genomic analysis as a significant part of disease diagnosis and personalized medicine. Various public genome research initiatives have been undertaken and enhancing focus on genomics health futures mission for the improvement of research & development activities. The extensive investments on R & D activities to expand access to new research capabilities, clinical trials, and technologies for betterment of healthcare sector which is acting as another growth-inducing factor. The increase in genome mapping programs and extensive research activities on personalized medicine has further augmented the

Extensive R&D activities for Developing Novel Next Generation Sequencing Technologies Fuels the Market Growth

The rising R&D activities for producing therapies used in the treatment of genetic disorders will inflate the need for next generation sequencing procedure over the analysis period. With this, the elevating investments in R&D activities and high number of studies related to treatment of genetic disorders among individuals is going to support the growth of the market. Government bodies of developed economies such as United Kingdom have launched numerous policies and initiated acts for encouraging scientists and researchers to find solutions for treating chronic and rare ailments. All these aforementioned factors are expected to drive the market towards growth over the forecast period.

Escalating Demand for DNA Testing is Estimated to Witness the Market Growth

The growing demand for DNA testing owing to the continuous advancements in whole genome and exome sequencing procedures, which offers faster results and cost effectives of the process as compared to genotyping-based DNA microarray. This made manufacturers to launch the first commercial sequencer, MinIon, utilizing Nanopore technology was launched by Oxford Nanopore Technologies. The sequencer assists in identifying DNA by measuring the modifications in the electrical conductivity generated DNA strands passed through biological pore. This technology allowed the detection of outbreaks such as Zika virus. Various organizations worked on DNA sequencing technologies for applied genomic testing, by introducing GENIUS sequencer, which can sequence DNA anywhere.

DOWNLOAD FREE SAMPLE REPORT

Market Segmentation

The United Kingdom next generation sequencing market is segmented


MIR Segment1

Market Players

Thermo Fischer Scientific, Inc., Illumina Cambridge Limited, PerkinElmer (UK) Limited, Agilent Technologies UK Limited, Qiagen Manchester Limited, Oxford Nanopore Technologies Limited, Roche Diagnostics Limited, are the significant market players operating in United Kingdom next generation sequencing market.

Attribute

Details

Base Year

2021

Historic Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Product

·         Technology

·         Application

·         End User

Regional scope

London, Southeast, East Anglia, Scotland, Southwest, East Midlands, and Yorkshire & Humberside

Key companies profiled

Thermo Fischer Scientific, Inc., Illumina Cambridge Limited, PerkinElmer (UK) Limited, Agilent Technologies UK Limited, Qiagen Manchester Limited, Oxford Nanopore Technologies Limited, Roche Diagnostics Limited

Customization scope

10% free report customization with purchase. Addition or alteration to regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Table of Content

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

List Tables Figures

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.